Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
169,2 USD | +0,42 % | +0,53 % | -14,27 % |
27/03 | Zoetis Inc recibe una propuesta de accionista de John Chevedden | CI |
26/03 | La Comisión Europea abre una investigación antimonopolio sobre Zoetis | MT |
Resumen de negocios
- animales de compañía (64,4%): gatos y perros (94,9% de las ventas netas) y caballos (5,1%);
- ganado (34,5%): vacuno (51,6% de las ventas), porcino (20,2%), aves de corral (17,1%), peces (7,6%) y otros (3,5%);
- otros (1,1%).
Las ventas netas se desglosan por familias de productos en parasiticidas (23%), vacunas (21,3%), productos dermatológicos (16,4%), antiinfecciosos (13,4%), aditivos alimentarios médicos (4,5%), productos de diagnóstico (4,4%) y otros (17%).
A finales de 2022, el grupo cuenta con 29 centros de producción en todo el mundo.
Estados Unidos representa el 53,4% de las ventas netas.
Número de empleados: 14 100
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Parasiticides
22,8
%
| 1 860 | 23,0 % | 1 947 | 22,8 % | +4,68 % |
Vaccines
20,7
%
| 1 718 | 21,3 % | 1 771 | 20,7 % | +3,08 % |
Dermatology
16,7
%
| 1 329 | 16,4 % | 1 427 | 16,7 % | +7,37 % |
Other Pharmaceuticals
15,0
%
| 1 043 | 12,9 % | 1 280 | 15,0 % | +22,72 % |
Anti-infectives
12,4
%
| 1 081 | 13,4 % | 1 057 | 12,4 % | -2,22 % |
Animal Health Diagnostics
4,4
%
| 353 | 4,4 % | 376 | 4,4 % | +6,52 % |
Medicated Feed Additives
4,1
%
| 360 | 4,5 % | 354 | 4,1 % | -1,67 % |
Other Non-pharmaceuticals
3,0
%
| 250 | 3,1 % | 254 | 3,0 % | +1,60 % |
Contract Manufacturing and Human Health
0,9
%
| 86 | 1,1 % | 78 | 0,9 % | -9,30 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
53,3
%
| 4 313 | 53,4 % | 4 555 | 53,3 % | +5,61 % |
Other Emerging Markets
9,2
%
| 758 | 9,4 % | 784 | 9,2 % | +3,43 % |
Other Developed Markets
6,0
%
| 468 | 5,8 % | 512 | 6,0 % | +9,40 % |
Brazil
4,6
%
| 330 | 4,1 % | 393 | 4,6 % | +19,09 % |
Australia
3,8
%
| 289 | 3,6 % | 323 | 3,8 % | +11,76 % |
China
3,7
%
| 382 | 4,7 % | 320 | 3,7 % | -16,23 % |
United Kingdom
3,2
%
| 235 | 2,9 % | 277 | 3,2 % | +17,87 % |
Canada
3,0
%
| 238 | 2,9 % | 255 | 3,0 % | +7,14 % |
Germany
2,4
%
| 176 | 2,2 % | 202 | 2,4 % | +14,77 % |
Mexico
1,9
%
| 136 | 1,7 % | 162 | 1,9 % | +19,12 % |
Japan
1,8
%
| 173 | 2,1 % | 158 | 1,8 % | -8,67 % |
France
1,7
%
| 126 | 1,6 % | 142 | 1,7 % | +12,70 % |
Chile
1,6
%
| 141 | 1,7 % | 140 | 1,6 % | -0,71 % |
Spain
1,4
%
| 118 | 1,5 % | 122 | 1,4 % | +3,39 % |
Italy
1,4
%
| 111 | 1,4 % | 121 | 1,4 % | +9,01 % |
Global
0,9
%
| 86 | 1,1 % | 78 | 0,9 % | -9,30 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Kristin Peck
CEO | Chief Executive Officer | 52 | 01/01/12 |
Wetteny Joseph
DFI | Director of Finance/CFO | 52 | 01/06/21 |
Mike McFarland
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/11 |
Robert Polzer
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/01/15 |
Wafaa Mamilli
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/01/20 |
Roxanne Lagano
COO | Chief Operating Officer | 59 | 01/10/12 |
Steven Frank
IRC | Investor Relations Contact | - | 01/03/15 |
William Dorsey
PRN | Corporate Officer/Principal | - | - |
Ester Banque
PRN | Corporate Officer/Principal | - | 10/07/23 |
Abhay Nayak
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 71 | 01/01/13 | |
Louise Parent
BRD | Director/Board Member | 73 | 01/08/13 |
Robert Scully
BRD | Director/Board Member | 74 | 01/06/13 |
Kristin Peck
CEO | Chief Executive Officer | 52 | 01/01/12 |
Paul Bisaro
BRD | Director/Board Member | 63 | 01/05/15 |
Frank D'Amelio
BRD | Director/Board Member | 66 | 01/07/12 |
Sanjay Khosla
BRD | Director/Board Member | 71 | 01/06/13 |
Gregory Norden
BRD | Director/Board Member | 66 | 01/01/13 |
Director/Board Member | 55 | 25/07/22 | |
Willie Reed
BRD | Director/Board Member | 69 | 04/03/14 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 501 391 000 | 456 706 815 ( 91,09 %) | 43 523 885 ( 8,681 %) | 91,09 % |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Pharmaq AS
Pharmaq AS Pharmaceuticals: MajorHealth Technology PHARMAQ AS operates as a veterinary pharmaceutical company. It provides health products to the global aquaculture industry. The company was founded on July 23, 2004 and is headquartered in Overhalla, Norway. |
Pharmaceuticals: Major
|
Zoetis India Ltd.
Zoetis India Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2007, Zoetis India Ltd. is a subsidiary of Zoetis, Inc. that manufactures vaccines and injectable biologic medicines. The private company is based in Mumbai, India. |
Pharmaceuticals: Major
|
Zoetis Treasury Center BV
| |
Zoetis Belgium SA
Zoetis Belgium SA BiotechnologyHealth Technology Part of Zoetis, Inc., Zoetis Belgium SA is a Belgian company that manufactures animal vaccines and prescription medicines. The private company is based in Louvain-La-Neuve, Belgium. |
Biotechnology
|
Zoetis Singapore Pte Ltd.
| |
Zoetis Vietnam LLC
Zoetis Vietnam LLC Pharmaceuticals: MajorHealth Technology Zoetis Vietnam LLC engages in the distribution of medicine and vaccinations for pets and livestocks. The company was founded on August 16, 2013 and is headquartered in Ho Chi Minh City, Vietnam. |
Pharmaceuticals: Major
|
Zoetis Pharmaceutical Research Pvt Ltd.
| |
Zoetis Korea Ltd.
Zoetis Korea Ltd. Pharmaceuticals: MajorHealth Technology Part of Zoetis, Inc., Zoetis Korea Ltd. is a South Korean company that manufactures veterinary medicinal preparations. The private company is located in South Korea. |
Pharmaceuticals: Major
|
Pharmaq Vietnam Co. Ltd.
|
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-14,27 % | 77,48 mil M | |
+9,26 % | 8025,55 M | |
+4,62 % | 3106,06 M | |
-3,76 % | 3128,02 M | |
-21,25 % | 1319,71 M | |
+9,80 % | 1390,46 M | |
-20,24 % | 1292,44 M | |
-2,83 % | 1271,6 M | |
-14,08 % | 1129,46 M | |
+4,89 % | 950 M |
- Bolsa
- Acciones
- Acción Zoetis Inc. - Nyse
- Empresa Zoetis Inc.